Starling Oncology (STLNW) Change in Taxes (2021 - 2023)

Starling Oncology (STLNW) has reported Change in Taxes for 3 consecutive years, with -$255000.0 the latest figure, recorded in Q4 2023.

• For the quarter ending Q4 2023, Change in Taxes fell 93.18% year-over-year to -$255000.0; the trailing twelve-month figure through Dec 2023 stood at -$133000.0 (down 208.13% YoY), and the FY2023 full-year result was -$255000.0, down 307.32% from the prior year.
• Change in Taxes eased to -$255000.0 in Q4 2023 per STLNW's latest filing, from -$1000.0 in the prior quarter.
• Across five years, Change in Taxes topped out at $4.4 million in Q3 2021 and bottomed at -$6.0 million in Q4 2021.
• Historically, Change in Taxes has averaged -$143125.0 across 3 years, with a median of $50500.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Change in Taxes soared 97.81% in 2022, then sank 100.39% in 2023.
• Over 3 years, Change in Taxes stood at -$6.0 million in 2021, then jumped by 97.81% to -$132000.0 in 2022, then tumbled by 93.18% to -$255000.0 in 2023.
• According to Business Quant data, Change in Taxes over the past three periods registered -$255000.0, -$1000.0, and -$132000.0 for Q4 2023, Q3 2023, and Q4 2022 respectively.